Streetbeat News

Stock Prices

TGL

Treasure Global shares rise following the completion of its at-the-market equity offering program.

Portfolio Pulse from Benzinga Newsdesk

October 02, 2024 | 11:55 am

ICCT

ICoreConnect shares rose following the announcement of its decision to divest its managed service provider division.

Portfolio Pulse from Benzinga Newsdesk

October 02, 2024 | 11:54 am

LPLA

LPL Financial Holdings' shares are declining following the termination of CEO Dan Arnold due to a breach of the company's commitment to a respectful workplace.

Portfolio Pulse from Benzinga Newsdesk

October 02, 2024 | 11:40 am

ATHE

Alterity Therapeutics presented multiple oral and poster presentations at the International Congress of Parkinson's Disease and Movement Disorders, highlighting their ongoing research and developments.

Portfolio Pulse from Benzinga Newsdesk

October 02, 2024 | 11:40 am

CAG

ConAgra Brands shares declined following the release of disappointing Q1 financial results.

Portfolio Pulse from Benzinga Newsdesk

October 02, 2024 | 11:36 am

CME

CME Group reported record-breaking average daily volumes for Q3 and September 2024, with 28.3 million and 28.4 million contracts respectively. Growth was observed across all asset classes.

Portfolio Pulse from Benzinga Newsdesk

October 02, 2024 | 11:33 am

CAG

Conagra Brands reported Q1 earnings of $0.53 per share, missing the $0.60 estimate, and sales of $2.79 billion, missing the $2.84 billion estimate. Both earnings and sales decreased compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

October 02, 2024 | 11:33 am

BCRX

BioCryst Pharmaceuticals has started a Phase 1 trial for BCX17725, targeting Netherton Syndrome, a genetic disorder. Initial data from the trial is expected by the end of 2025.

Portfolio Pulse from Benzinga Newsdesk

October 02, 2024 | 11:04 am

LLY

NVO

Eli Lilly is on the verge of becoming the first trillion-dollar pharmaceutical company, driven by the success of its weight loss drugs. However, investors are cautious due to its high valuation and potential competition. The company is investing heavily in R&D to maintain its market position.

Portfolio Pulse from Vandana Singh

October 02, 2024 | 11:03 am